ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 173 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,073,000 | -65.3% | 50,000 | -66.2% | 0.13% | -75.0% |
| Q3 2016 | $3,090,000 | +23.6% | 148,000 | +51.0% | 0.50% | -22.5% |
| Q2 2016 | $2,499,000 | +29.4% | 98,000 | +34.2% | 0.65% | +54.9% |
| Q1 2016 | $1,931,000 | -68.4% | 73,000 | -49.0% | 0.42% | -53.2% |
| Q4 2015 | $6,118,000 | -14.5% | 143,000 | -47.0% | 0.90% | -1.9% |
| Q3 2015 | $7,158,000 | +43.2% | 270,000 | +80.0% | 0.91% | +86.3% |
| Q2 2015 | $5,000,000 | +54.7% | 150,000 | +89.6% | 0.49% | -11.1% |
| Q4 2014 | $3,233,000 | -52.1% | 79,105 | -60.3% | 0.55% | -33.9% |
| Q3 2014 | $6,746,000 | +33.4% | 199,105 | +32.7% | 0.83% | -33.1% |
| Q2 2014 | $5,057,000 | – | 150,000 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |